Human papillomavirus vaccine TA-HPV (Xenova)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman papillomavirus vaccine TA-HPV (Xenova)

Drug Alias NameTA-HPV

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulantsImmunomodulators

TargetsProtein E7Protein E6

Therapy Area/IndicationsAnal intraepithelial neoplasiaVulvar NeoplasmsUterine Cervical Neoplasms +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCeltic Group Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCeltic Group Inc

Active IndicationsN/A

Inactive IndicationsAnal intraepithelial neoplasiaVulvar NeoplasmsUterine Cervical Neoplasms +[4]

Other Information

ATC CodeN/A